“So far, it is known that ergotamine interacts with diverse receptors (including α1/2-adrenoceptors, 5-HT1, 5-HT2 and D2-like receptors) and that produces increases in mean blood pressure which are significantly blocked by yohimbine , a classical α2-adrenoceptor antagonist with a moderate affinity for α1-adrenoceptors.”